Detalhe da pesquisa
1.
Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Clin Immunol
; 191: 10-20, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518577
2.
The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.
Clin Exp Rheumatol
; 34(2): 318-28, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26966791
3.
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial.
Arthritis Rheumatol
; 69(10): 1969-1977, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28845577